BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,070 filers reported holding BAXTER INTL INC in Q3 2021. The put-call ratio across all filers is 0.84 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $768,952 | +162.5% | 20,375 | +216.9% | 0.03% | +160.0% |
| Q2 2023 | $292,905 | +12.3% | 6,429 | 0.0% | 0.01% | +11.1% |
| Q1 2023 | $260,760 | +98300.0% | 6,429 | +23.7% | 0.01% | -10.0% |
| Q4 2022 | $265 | -99.9% | 5,198 | -4.6% | 0.01% | -44.4% |
| Q3 2021 | $438,000 | -0.2% | 5,450 | 0.0% | 0.02% | 0.0% |
| Q2 2021 | $439,000 | -4.6% | 5,450 | -0.0% | 0.02% | -10.0% |
| Q1 2021 | $460,000 | +99.1% | 5,452 | +89.5% | 0.02% | +66.7% |
| Q3 2020 | $231,000 | -79.9% | 2,877 | -78.5% | 0.01% | -80.3% |
| Q2 2020 | $1,151,000 | -8.1% | 13,363 | -13.4% | 0.06% | -19.7% |
| Q1 2020 | $1,252,000 | +2.7% | 15,424 | +5.8% | 0.08% | +31.0% |
| Q4 2019 | $1,219,000 | -24.9% | 14,580 | -21.4% | 0.06% | -31.0% |
| Q3 2019 | $1,623,000 | +16.8% | 18,554 | +9.4% | 0.08% | +13.5% |
| Q2 2019 | $1,389,000 | +4.7% | 16,962 | +3.9% | 0.07% | +4.2% |
| Q1 2019 | $1,327,000 | -6.0% | 16,318 | -23.9% | 0.07% | -16.5% |
| Q4 2018 | $1,411,000 | -13.9% | 21,438 | +0.9% | 0.08% | -1.2% |
| Q3 2018 | $1,639,000 | +1662.4% | 21,256 | +1491.0% | 0.09% | +352.6% |
| Q2 2013 | $93,000 | – | 1,336 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |